Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Affordability and Sustainability improvements by using new pricing, Cost-Effectiveness and ReimbursemenT models to Appraise iNnovative health technologies

Project description

Novel tools will improve the affordability and accessibility of healthcare technologies

The good health and well-being of individuals is an essential pillar of a healthy and productive society. Achieving this requires equal access to modern health technologies, both physically and financially. The EU-funded ASCERTAIN project will address the need of patients, physicians, payers, regulators and manufacturers to improve the affordability of and access to innovative health technologies for Europe’s inhabitants. It will develop open-access, easy to use, policy-supporting tools including pricing models, value assessment models and reimbursement models adaptable to country-specific conditions. Use of these will improve transparency and accountability, reduce uncertainty, reward innovation, accelerate patient access and support long-term planning in a sustainable way.

Objective

ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and ReimbursemenT models to Appraise iNnovative health technologies) addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies (including pharmaceuticals) in Europe. ASCERTAIN aims to enhance current methods of (value-based) pricing, cost-effectiveness modeling, threshold-setting, reimbursement, and payment, to set affordable prices, and to facilitate a cyclic assessment of broader societal benefits including costs and risks. It seeks to find a sustainable balance between access to affordable technologies, the need to stimulate innovation and entrepreneurship, and the need to consider the environmental impact of innovations. Guided by a conceptual framework integrating pricing, health technology assessment and reimbursement/payment, ASCERTAIN will develop open-access, easy to use, policy-supporting tools including (i) pricing models, (ii) value assessment models, and (iii) reimbursement models, which will be adaptable to country-specific conditions. These tools will improve transparency and accountability of decision-making, reduce uncertainty for all stakeholders, reward innovation in areas of high unmet need, accelerate access for patients, and support long-term planning in a sustainable way. Further, these tools will be developed, tested, and validated for three use cases, including precision cancer medicine, cell- and gene therapy, and medical devices (class IIb and III) or in vitro diagnostic (IVD) class D. The multinational, multidisciplinary ASCERTAIN consortium is complemented by an international advisory board consisting of key stakeholders, with whom the policy-supporting tools will be co-created. All tools will be hosted on a cloud-based, publicly accessible, user-friendly platform following open science principles.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-RIA - HORIZON Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-HLTH-2022-IND-13

See all projects funded under this call

Coordinator

ERASMUS UNIVERSITEIT ROTTERDAM
Net EU contribution
€ 1 450 097,83
Address
BURGEMEESTER OUDLAAN 50
3062 PA Rotterdam
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 450 097,83

Participants (9)